Display options
Cite
Hansmann G. Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists. Pulm Circ. 2013;3(4):792-801doi: 10.1086/674766.
Hansmann, G. (2013). Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists. Pulmonary circulation, 3(4), 792-801. https://doi.org/10.1086/674766
Hansmann, Georg. "Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists." Pulmonary circulation vol. 3,4 (2013): 792-801. doi: https://doi.org/10.1086/674766
Hansmann G. Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists. Pulm Circ. 2013 Dec;3(4):792-801. doi: 10.1086/674766. PMID: 25006395; PMCID: PMC4070820.
Copy Download .nbib Format: NLM
Share it on

Pulm Circ. 2013 Dec;3(4):792-801. doi: 10.1086/674766.

Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists.

Pulmonary circulation

Georg Hansmann

Affiliations

  1. Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.

PMID: 25006395 PMCID: PMC4070820 DOI: 10.1086/674766

Abstract

The pathobiology of pulmonary arterial hypertension (PAH) is complex and multifactorial. None of the current therapies has been shown to be universally effective or able to reverse advanced pulmonary vascular disease, characterized by plexiform vascular lesions, or to prevent right ventricular failure in advanced PAH. It is thus unlikely that only one factor, pathway, or gene mutation will explain all forms and cases. Pediatric oncologists recognized a need for intensified, collaborative research within their field more than 40 years ago and implemented major clinical and translational networks worldwide to achieve evidence-based "tailored therapies." The similarities in the pathobiology (e.g., increased proliferation and resistance to apoptosis in vascular cells and perivascular inflammation) and the uncertainties in the proper treatment of both cancer and pulmonary hypertension (PH) have led to the idea of building interdisciplinary networks among PH centers to achieve rapid translation of basic research findings, optimal diagnostic algorithms, and significant, sustained treatment results. Such networks leading to patient registries, clinical trials, drug development, and innovative, effective therapies are urgently needed for the care of children with PH. This article reviews the current status, limitations, and recent developments in the field of pediatric PH. It is suggested that the oncologists' exemplary networks, concepts, and results in the treatment of acute lymphoblastic leukemia are applicable to future networks and innovative therapies for pediatric pulmonary hypertensive vascular disease and right ventricular dysfunction.

Keywords: children; clinical trial; neonates; network; pulmonary hypertension; vascular disease

References

  1. Heart. 2005 Aug;91(8):1064-9 - PubMed
  2. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D117-26 - PubMed
  3. Circulation. 2010 May 11;121(18):2045-66 - PubMed
  4. Chest. 2010 Jun;137(6 Suppl):69S-77S - PubMed
  5. Circulation. 2012 Jan 3;125(1):113-22 - PubMed
  6. Pulm Circ. 2011 Aug 2;1(2):280-285 - PubMed
  7. Eur Respir J. 2007 Jul;30(1):104-9 - PubMed
  8. Pulm Circ. 2011;1(2):286-298 - PubMed
  9. J Clin Invest. 2012 Dec;122(12):4306-13 - PubMed
  10. Pharmacol Ther. 2009 Jan;121(1):69-88 - PubMed
  11. Circulation. 2008 Sep 9;118(11):1195-201 - PubMed
  12. Circulation. 2012 Nov 27;126(22):2601-11 - PubMed
  13. Cancer Cell. 2007 Jan;11(1):37-51 - PubMed
  14. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9 - PubMed
  15. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41 - PubMed
  16. J Am Coll Cardiol. 2005 Jun 7;45(11):1849-55 - PubMed
  17. Circulation. 2006 Oct 3;114(14):1482-9 - PubMed
  18. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D60-72 - PubMed
  19. Circulation. 2008 Sep 30;118(14):1486-95 - PubMed
  20. Eur Respir J. 2009 Feb;33(2):318-24 - PubMed
  21. Sci Transl Med. 2013 Oct 23;5(208):208sr5 - PubMed
  22. Pulm Circ. 2013 Jan;3(1):217-25 - PubMed
  23. Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30 - PubMed
  24. Circulation. 2007 Mar 13;115(10):1275-84 - PubMed
  25. Circulation. 2011 Oct 18;124(16):1755-64 - PubMed
  26. Eur Heart J. 2009 Oct;30(20):2493-537 - PubMed
  27. Pulm Circ. 2013 Jan;3(1):203-5 - PubMed
  28. Chest. 1998 Sep;114(3 Suppl):225S-230S - PubMed
  29. Ann Intern Med. 1991 Sep 1;115(5):343-9 - PubMed
  30. Am J Respir Crit Care Med. 2010 Sep 1;182(5):661-8 - PubMed
  31. Radiology. 2004 Dec;233(3):774-80 - PubMed
  32. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33 - PubMed
  33. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1131-42 - PubMed
  34. Lancet. 2012 Feb 11;379(9815):537-46 - PubMed
  35. Am J Respir Crit Care Med. 2010 Dec 15;182(12):1554-62 - PubMed
  36. Arch Cardiovasc Dis. 2010 Feb;103(2):66-74 - PubMed
  37. Leukemia. 2000 Dec;14(12):2307-20 - PubMed
  38. Am J Respir Crit Care Med. 2010 Nov 1;182(9):1171-7 - PubMed
  39. Pulm Circ. 2013 Jan;3(1):245-51 - PubMed
  40. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S10-S19 - PubMed
  41. J Clin Invest. 2008 May;118(5):1846-57 - PubMed
  42. Circulation. 2002 Jan 15;105(2):244-50 - PubMed
  43. Circ Res. 2004 Oct 15;95(8):830-40 - PubMed
  44. J Clin Invest. 2013 Aug;123(8):3600-13 - PubMed
  45. Circulation. 2008 Apr 1;117(13):1717-31 - PubMed
  46. Curr Vasc Pharmacol. 2012 May;10(3):289-99 - PubMed
  47. Heart. 2010 Sep;96(17):1401-6 - PubMed
  48. Circulation. 2009 Apr 28;119(16):2250-94 - PubMed
  49. Heart. 2010 Sep;96(17):1337-8 - PubMed
  50. Circulation. 2012 May 1;125(17):2165-70 - PubMed
  51. Chest. 2010 Jun;137(6 Suppl):95S-101S - PubMed
  52. Circ Res. 2005 Mar 4;96(4):442-50 - PubMed
  53. Circulation. 2013 Mar 12;127(10):1128-38 - PubMed
  54. Circulation. 2010 Jun 22;121(24):2661-71 - PubMed
  55. J Am Coll Cardiol. 2008 Nov 18;52(21):1683-92 - PubMed
  56. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30 - PubMed
  57. Circulation. 2011 Jun 28;123(25):2919-21 - PubMed
  58. Eur Respir J. 2013 Sep;42(3):689-700 - PubMed
  59. Am J Respir Crit Care Med. 2008 Jan 1;177(1):108-13 - PubMed
  60. Pulm Circ. 2012 Apr-Jun;2(2):170-81 - PubMed
  61. Pulm Circ. 2013 Jan;3(1):206-16 - PubMed
  62. Sci Transl Med. 2009 Dec 23;1(12):12ps14 - PubMed

Publication Types